Results for tag: "Respiratory Distress Syndrome Drug"

Respiratory Distress Syndrome (RDS) is a type of respiratory disorder that affects newborns. It is caused by a lack of surfactant, a substance that helps keep the lungs open and functioning properly. Treatment for RDS includes the use of drugs that help to increase the production of surfactant in the lungs. These drugs are known as surfactant replacement therapy (SRT) drugs. SRT drugs are used to treat RDS in newborns and are typically administered through a tube inserted into the baby's trachea. The drugs are designed to help the baby's lungs stay open and functioning properly. They can also help reduce the risk of complications associated with RDS, such as pneumonia and respiratory failure. The market for RDS drugs is highly competitive, with many companies offering different types of SRT drugs. Some of the major players in the market include GlaxoSmithKline, Abbott Laboratories, Merck & Co., and Novartis. Other companies that offer SRT drugs include Chiesi, Baxter, and Mallinckrodt. Show Less Read more